BTG gains dielectrophoresis, dialysis technology rights
This article was originally published in Clinica
Executive Summary
UK technology transfer company BTG's health, medical and biotechnologies division has gained commercialisation rights to two technologies - one has market potential in the $25 billion dialysis market, while the other is a microelectronics and life sciences patent portfolio with diagnostic possibilities.